FMP

FMP

Enter

Edward Tenthoff Sets Optimistic Price Target for Moderna (NASDAQ: MRNA)

- (Last modified: Nov 19, 2024 9:14 AM)

twitterlinkedinfacebook
blog post cover photo

Image credit: Google Images

  • Edward Tenthoff from Piper Sandler set a price target of $69 for Moderna (NASDAQ: MRNA), indicating a potential upside of 85.13%.
  • Moderna's presence at Guggenheim's Inaugural Healthcare Innovation Conference highlighted its ongoing contributions to healthcare innovation.
  • The company's stock has shown volatility with a year-high of $170.47 and a low of $35.80, reflecting the dynamic market response to its developments.

On November 18, 2024, Edward Tenthoff from Piper Sandler set a price target of $69 for Moderna (NASDAQ: MRNA). At the time, the stock was trading at $37.27, suggesting a potential upside of 85.13%. Moderna is a biotechnology company known for its mRNA technology, which played a crucial role in developing COVID-19 vaccines. It competes with other biotech firms like Pfizer and BioNTech.

At the Guggenheim's Inaugural Healthcare Innovation Conference on November 12, 2024, Moderna's President, Stephen Hoge, represented the company. The event, led by Evan Wang, a senior biotech analyst at Guggenheim Securities, highlighted Moderna's ongoing contributions to healthcare innovation. This focus on innovation aligns with the optimistic price target set by Edward Tenthoff.

Currently, Moderna's stock is priced at $38.47, reflecting a 4.40% increase or $1.62 gain. The stock has fluctuated between $37.10 and $38.86 today. Over the past year, it reached a high of $170.47 and a low of $35.80. This volatility indicates the market's dynamic response to Moderna's developments and broader industry trends.

Moderna's market capitalization is approximately $14.80 billion, reflecting its significant presence in the biotech sector. The trading volume for the day is 5,805,352 shares on the NASDAQ exchange, indicating active investor interest. This trading activity suggests that investors are closely monitoring Moderna's performance and potential growth prospects.

The price target set by Edward Tenthoff and the discussions at the Guggenheim conference underscore the market's interest in Moderna's future. As the company continues to innovate in healthcare, its stock performance remains a focal point for investors seeking growth opportunities in the biotech industry.

Other Blogs

May 14, 2024 11:41 AM - Sanzhi Kobzhan

The easiest way to calculate stock’s target price and why the target price is important.

A stock's target price, also known as its fair value, is an indication of what a share can cost based on the company’s forecasted financial statements. It is important to know a stock's fair value to find undervalued stocks with great growth potential. Let's consider how investment analysts calculat...

blog post title

May 24, 2024 9:30 AM - Rajnish Katharotiya

How to Access and Analyze Earnings Call Transcripts

Earnings call transcripts are invaluable resources for investors, analysts, and financial enthusiasts. They provide insights into a company's performance, strategy, and future outlook, making them essential for making informed investment decisions. With Financial Modeling Prep, Earnings Call Transcr...

blog post title

May 27, 2024 3:30 PM - Rajnish Katharotiya

The best 5 GPU stocks other than NVDA

In the ever-evolving world of technology, certain sectors have consistently demonstrated exceptional growth and innovation. The graphics processing units (GPUs) industry is one such sector, offering investors a golden opportunity for potentially high returns. In this blog, we'll delve into why inves...

blog post title
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep